Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Fiona Watt wins prestigious Michael Mason Prize 2016.

Dr Fiona Watt, of the Kennedy Institute of Rheumatology is the winner of the prestigious Michael Mason Prize 2016 awarded by the British Society for Rheumatology, for her contributions to the field.

The award represents the increasing interest in osteoarthritis research in recent years and desire to find new ways to treat the disease: osteoarthritis remains the leading cause of joint pain and disability in the UK, and major reason for joint replacement.
- Dr Fiona Watt

Fiona is a Senior Clinical Research Fellow at NDORMS, as well as an honorary consultant rheumatologist at the Nuffield Orthopaedic Centre. Her research work focuses on human clinical studies and trials relevant to osteoarthritis within the Arthritis Research UK Centre for Osteoarthritis Pathogenesis, where she also leads the Clinical Translation theme.

Her research interest is in the early diagnosis, stratification and treatment of osteoarthritis and she is involved with a number of groups and steering committees which focus on the treatment of this condition.

Speaking of her award, Fiona says: "It is a great honour to be this year's recipient of the Michael Mason prize. The award represents the increasing interest in osteoarthritis research in recent years and desire to find new ways to treat the disease: osteoarthritis remains the leading cause of joint pain and disability in the UK, and major reason for joint replacement. Joint injury is the single greatest risk factor for developing osteoarthritis, which often affects people in mid-life.

"Our work relating to the responses of joint tissues to injury and subsequently in individuals with recent joint injury represents work over many years by myself and colleagues at the Kennedy Institute for Rheumatology. By testing discoveries from the laboratory in clinical studies, we aim to find better of ways of predicting the onset of arthritis, and developing medical treatments which can slow or prevent arthritis, and improve joint pain for people with the condition".

The Michael Mason Prize is awarded by the Heberden Committee for excellence in clinical or scientific research in the field of rheumatology. Dr Michael Mason was a renowned clinical rheumatologist, qualified from Oxford and St Bartholomew's Hospital London. His practice was in the wider aspects of rheumatology and together with Dr W S Tegner he established an associated academic professorial unit in Rheumatology in the University of London at the London Hospital Medical College. Additionally he was instrumental in the development of the Bone and Joint Research at the London Hospital Medical College.

Similar stories

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.

HOPE-c opens up for recruitment

Researchers in the Centre for OA Pathogenesis Versus Arthritis at the Kennedy Institute of Rheumatology and Imperial College London are looking to recruit adults with painful hand osteoarthritis for an observational study to help uncover why people living with the condition experience different patterns of pain.